Cargando…
Synthesis, (68)Ga-Radiolabeling, and Preliminary In Vivo Assessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent
Noninvasive imaging is a powerful tool for early diagnosis and monitoring of various disease processes, such as infections. An alarming shortage of infection-selective radiopharmaceuticals exists for overcoming the diagnostic limitations with unspecific tracers such as (67/68)Ga-citrate or (18)F-FDG...
Autores principales: | Mokaleng, Botshelo B., Ebenhan, Thomas, Ramesh, Suhas, Govender, Thavendran, Kruger, Hendrik G., Parboosing, Raveen, Hazari, Puja P., Mishra, Anil K., Marjanovic-Painter, Biljana, Zeevaart, Jan R., Sathekge, Mike M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324493/ https://www.ncbi.nlm.nih.gov/pubmed/25699267 http://dx.doi.org/10.1155/2015/284354 |
Ejemplares similares
-
Preclinical Assessment of a (68)Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent
por: Ebenhan, Thomas, et al.
Publicado: (2017) -
Development of a Single Vial Kit Solution for Radiolabeling of (68)Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
por: Ebenhan, Thomas, et al.
Publicado: (2015) -
Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi(8), Met(O(2))(11)]-Substance P for Future Clinical Application: First Experiences
por: Suthiram, Janine, et al.
Publicado: (2021) -
(68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
por: Sathekge, Mike, et al.
Publicado: (2016) -
(68)Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans
por: Sathekge, Mike, et al.
Publicado: (2017)